SUBSCRIBE
SUBSCRIBE
News   Deals

China’s Simcere Pharmaceutical Group Files with U.S. for $120 Million IPO

March 26, 2007 | 
1 min read
WASHINGTON, March 23 (Reuters) - China's Simcere Pharmaceutical Group on Friday said it is planning an initial public offering of as much as $120 million in American depositary shares.

>>> Discuss This Story

IPO
MORE ON THIS TOPIC
Joint pain anatomy medical concept
Pain
Lilly Follows Vertex Into Non-Opioid Pain With up to $1B SiteOne Buy
May 27, 2025
 · 
2 min read
 · 
Annalee Armstrong
ASD autism neurodevelopmental spectrum disorder, deficits in social communication and interaction, brain with impairment, hypersensitivity and abnormalities
Neuroscience
Epilepsy Biotech Nabs up to $570M in Deal With Italy’s Angelini Plus $140M Fundraising
May 27, 2025
 · 
1 min read
 · 
Annalee Armstrong
Neurology, philosophy: connections, the development of thought and reflection, the infinite possibilities of the brain and mind. Creativity stock photo
Mergers & acquisitions
Sanofi Buys Vigil for $470M Upfront, Reigniting a Battered Alzheimer’s Target
May 22, 2025
 · 
4 min read
 · 
Annalee Armstrong
Business teamwork. Collaboration of entrepreneurs to achieve success. Partners communicate with each other and discuss cooperation. Cartoon flat vector illustration isolated on light background
NextGen
In Biotech’s ‘Moribund’ Market, What Does It Take To Survive?
May 21, 2025
 · 
6 min read
 · 
Annalee Armstrong